ChiCTR2200060526: A single-center, randomized, parallel, open clinical trial comparing the bioavailability, pharmacokinetics and safety of single subcutaneous injection of SHR-1209 in healthy subjects at different sites |
|
|
| Not yet recruiting | 1 | 159 | | Single subcutaneous injection of SHR-1209 in the predetermined area A ;Single subcutaneous injection of SHR-1209 in the predetermined area B ;Single subcutaneous injection of SHR-1209 in the predetermined area C | The Second Hospital of Anhui Medical University; The Second Hospital of Anhui Medical University, Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Hyperlipidemia | | | | |
NCT05370950: Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injection at Different Sites in Healthy Volunteers |
|
|
| Completed | 1 | 159 | RoW | SHR-1209 | Jiangsu HengRui Medicine Co., Ltd. | Hypercholesterolemia and Hyperlipidemia | 12/22 | 12/22 | | |
